Hippo pathway signaling and YAP/TAZ
Hippo pathway signaling and YAP/TAZ is a research topic within Cell Biology. Science Explorer counts 14k research works in it since 1952. 28.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of the Hippo signaling pathway, particularly the involvement of YAP/TAZ, in mechanotransduction, cell proliferation, tissue growth control, organ size control, and its implications in cancer and stem cell regulation.
- Hippo Pathway
- YAP/TAZ
- mechanotransduction
- cell proliferation
- tissue growth control
- organ size control
- cancer
- regulation
- mechanobiology
- stem cells
- Research works
- 14k fractional, since 1952
- In the world top 10%
- 4k per year above
- Top-10% rate
- 28.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +38% the tick is no change
Which countries lead Hippo pathway signaling and YAP/TAZ research?
By volume, China and the United States publish the most (1.2k and 638 works in 2022–2025).
By volume, 2022–2025
- 1 China 1.2k works
- 2 United States 638 works
- 3 Japan 127 works
- 4 South Korea 95 works
- 5 Germany 89 works
- 6 United Kingdom 87 works
- 7 France 80 works
- 8 Canada 69 works
- 9 India 63 works
- 10 Italy 51 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hippo pathway signaling and YAP/TAZ research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Hippo pathway signaling and YAP/TAZ research, followed by Sichuan University and Shanghai Jiao Tong University.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 21 works
- 2 Sichuan UniversityChina 18 works
- 3 Shanghai Jiao Tong UniversityChina 16 works
- 4 Zhejiang UniversityChina 15 works
- 5 Central South UniversityChina 14 works
- 6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 14 works
- 7 Nanjing Medical UniversityChina 13 works
- 8 Baylor College of MedicineUnited States 13 works
- 9 Fudan UniversityChina 11 works
- 10 Huazhong University of Science and TechnologyChina 11 works
Who are the leading researchers in Hippo pathway signaling and YAP/TAZ?
The most-cited researchers publishing on Hippo pathway signaling and YAP/TAZ include Anil K. Sood.
- 1 Anil K. Sood United States 2.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Hippo pathway signaling and YAP/TAZ research done?
The largest centres of Hippo pathway signaling and YAP/TAZ research in 2022–2025 are Shanghai (China), Beijing (China), Guangzhou (China) and Hangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Houston and Nanchang.
Largest cities, 2022–2025
Where it is the local speciality
- HoustonUS · 32.7 works4.8×
- NanchangCN · 23.4 works4.7×
Location quotient: how much more of its research is in Hippo pathway signaling and YAP/TAZ than the world average.
Where is the best place to study Hippo pathway signaling and YAP/TAZ?
Among universities, judged by research, Southern Medical University, China Medical University and Sun Yat-sen University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Southern Medical UniversityChina | 67.6 | 43.6% | 9.1× | 9 | +196.8% |
| 2 | China Medical UniversityChina | 62.6 | 40.3% | 12.0× | 11 | +89.1% |
| 3 | Sun Yat-sen UniversityChina | 59.7 | 34.4% | 4.8× | 21 | +113.4% |
| 4 | Nanjing Medical UniversityChina | 56.7 | 21.3% | 9.4× | 13 | +627.4% |
| 5 | Soochow UniversityChina | 56.4 | 40.5% | 4.9× | 11 | +410.4% |
| 6 | Huazhong University of Science and TechnologyChina | 55.0 | 46.7% | 2.5× | 11 | +293.3% |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 54.8 | 42.3% | 5.3× | 14 | +49.0% |
| 8 | Tianjin Medical UniversityChina | 54.7 | 28.1% | 14.9× | 8 | +262.2% |
| 9 | Chongqing Medical UniversityChina | 54.1 | 23.9% | 10.8× | 10 | +413.8% |
| 10 | Sichuan UniversityChina | 49.8 | 25.1% | 3.8× | 18 | +213.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Hippo pathway signaling and YAP/TAZ research growing?
Output in 2018–2022 was 38% higher than in 2013–2017, peaking in 2020. The fastest-growing topics are Hippo pathway signaling and YAP/TAZ.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.